Related Experiment Videos
Therapy of hepatitis C: cost-effectiveness analysis
1Department of Medicine, Columbia MetroWest Medical Center, Framingham, MA 01702, USA.
Hepatology (Baltimore, Md.)
|September 26, 1997
Summary
Alpha interferon treatment for chronic hepatitis C increases life expectancy despite costs. This treatment is cost-effective, with potential for cost-savings if response rates improve or younger patients are treated.
Area of Science:
- Hepatology
- Health Economics
- Clinical Outcomes Research
Background:
- The natural history and long-term outcomes of untreated chronic hepatitis C are not fully understood.
- Limited data exists on the clinical and economic impact of current alpha interferon treatment regimens.